Dublin-domiciled group finally gets hold of MS drug revenue it initially pursed from Elan in 2013
Dublin-based drugmaker was urged last year to explore a sale of its prescription business
CEO John Hendrickson says drug faces increased competition and potential for wider use has failed to materialise
Company sales have halved since the company rejected Mylan takeover offer late last year
Joseph Papa confirms position day after he resigns from the top spot at drugmaker Perrigo
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices